CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
The US is the world's largest producer of bioethanol as renewable liquid fuel, with more than 200 commercial plants processing over 16 billion gallons per year. Plants typically use dry grind ...
Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far Progress beyond the state of the art and expected potential impact ...
Dairy supplier Arla claims ‘revolutionary’ new technology to separate milk into its different protein components opens the door to ‘infinite innovation possibilities’. Milk protein fractionation using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results